The company's knowledge-primed AI engine integrates computational biology and functional genomics to uncover the molecular landscape of treatment response or resistance. This enables the development of drugs that work across a wide range of patient populations, override resistance mechanisms, and enable combinations by design. Serinus Biosciences is redefining precision in cancer therapeutics by designing models to determine how molecules function inside each tumor cell.